RSS Feeds
Hispanics with End-Stage Renal Disease
- Stephen E. Radecki, PhD; and
- Allen R. Nissenson, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
The recent National Institutes of Health consensus conference statement on the morbidity and mortality of renal dialysis noted that whereas the incidence of treated end-stage renal disease is dramatically higher for African-Americans and Native Americans than for other racial groups [1], a clinical impression of greater treated incidence in Hispanics could not be confirmed because of the unavailability of data on ethnicity in the United States Renal Data System [2]. National data from our 1980s dialysis practice study show that Hispanics accounted for 7.6% of the population of treated patients with end-stage renal disease at that time [3] compared with 6.4% of the resident population (1980 U.S. Census) [4]. Among end-stage renal disease subgroups, Hispanics have a 10.0% rate for diabetic nephropathy and a 4.1% rate for hypertensive nephropathy [3], rates consistent with overall ethnic patterns in mortality associated with these underlying diseases [5]. Although the subsequent increase in the number of Hispanics in the U.S. resident population [4] will have increased these figures, the findings corroborate the clinical impression cited above [1] by showing a slight over-representation of Hispanics among treated patients with end-stage renal disease.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
- Copyright ©2004 by the American College of Physicians
